Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Advanced Dermatology and Cosmetic Surgery
mi
from
Ormond Beach, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Advanced Dermatology and Cosmetic Surgery
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Stedman Clinical Trials
mi
from
Tampa, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Northwest Clinical Trials
mi
from
Boise, ID
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Northwest Clinical Trials
mi
from
Boise, ID
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Deaconess Clinic Downtown-Research Institute
mi
from
Evansville, IN
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Deaconess Clinic Downtown-Research Institute
mi
from
Evansville, IN
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
DermResearch, PLLC
mi
from
Louisville, KY
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Academic Dermatology
mi
from
Albuquerque, NM
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Academic Dermatology
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Wake Forest University Health Sciences - Dermatology Studies
mi
from
Winston-Salem, NC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Wake Forest University Health Sciences - Dermatology Studies
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Toledo Center for Clinical Research
mi
from
Sylvania, OH
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Toledo Center for Clinical Research
mi
from
Sylvania, OH
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Oklahoma University Health Sciences Center, Dermatology Dept
mi
from
Oklahoma City, OK
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Oklahoma University Health Sciences Center, Dermatology Dept
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Partners, LLC
mi
from
Johnston, RI
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Radiant Research
mi
from
Greer, SC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
J&S Studies
mi
from
College Station, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
J&S Studies
mi
from
College Station, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Baylor Research Institute of Dermatology Department
mi
from
Dallas, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Baylor Research Institute of Dermatology Department
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Dermatology Associates of San Antonio
mi
from
San Antonio, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Dermatology Associates of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Intermountain Clinical Research
mi
from
Draper, UT
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Intermountain Clinical Research
mi
from
Draper, UT
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Commonwealth Clinical Research Specialists, Inc.
mi
from
Richmond, VA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Commonwealth Clinical Research Specialists, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Premier Clinical Research
mi
from
Spokane, WA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated:  10/31/2015
Dermatology Research Area
mi
from
Davis, CA
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated: 10/31/2015
Dermatology Research Area
mi
from
Davis, CA
Click here to add this to my saved trials
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated:  10/31/2015
UC Davis Department of Dermatology
mi
from
Sacramento, CA
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated: 10/31/2015
UC Davis Department of Dermatology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis
Status: Enrolling
Updated:  11/3/2015
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis
Status: Enrolling
Updated: 11/3/2015
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
Status: Enrolling
Updated:  11/3/2015
UC Davis Department of Dermatology
mi
from
Sacramento, CA
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
Status: Enrolling
Updated: 11/3/2015
UC Davis Department of Dermatology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp
An Evaluation of the Effect of the Erchonia ML Scanner (MLS) on the Treatment of Androgenic Alopecia in Females
Status: Enrolling
Updated:  11/7/2015
Advanced Gynecology Specialists of Georgia
mi
from
Evans, GA
Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp
An Evaluation of the Effect of the Erchonia ML Scanner (MLS) on the Treatment of Androgenic Alopecia in Females
Status: Enrolling
Updated: 11/7/2015
Advanced Gynecology Specialists of Georgia
mi
from
Evans, GA
Click here to add this to my saved trials
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
Status: Enrolling
Updated:  11/9/2015
GSK Investigational Site
mi
from
Urbana, IL
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
Status: Enrolling
Updated: 11/9/2015
GSK Investigational Site
mi
from
Urbana, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Indianapolis, IN
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
San Diego, CA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Miami, FL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Alpharetta, GA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Arlington Heights, IL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Chicago, IL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Norfolk, VA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Bay City, MI
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Bay City, MI
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
New York, NY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Cleveland, OH
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Portland, OR
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
College Station, TX
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Anniston, AL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated:  11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated: 11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
Click here to add this to my saved trials
A Long-Term Safety and Efficacy Study of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Portland, OR
A Long-Term Safety and Efficacy Study of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of an Herbal-Based De-Pigmenting System
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System
Status: Enrolling
Updated:  11/17/2015
Sadick Research Group
mi
from
New York, NY
Evaluation of an Herbal-Based De-Pigmenting System
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System
Status: Enrolling
Updated: 11/17/2015
Sadick Research Group
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated:  11/18/2015
River City Dermatology
mi
from
Little Rock, AR
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated: 11/18/2015
River City Dermatology
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated:  11/18/2015
American Dermatology Associates
mi
from
Shawnee, KA
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated: 11/18/2015
American Dermatology Associates
mi
from
Shawnee, KA
Click here to add this to my saved trials